RNA Interference-directed Knockdown of Urokinase Plasminogen Activator and Urokinase Plasminogen Activator Receptor Inhibits Prostate Cancer Cell Invasion, Survival, and Tumorigenicity in Vivo
Open Access
- 1 October 2005
- journal article
- retracted article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 280 (43) , 36529-36540
- https://doi.org/10.1074/jbc.m503111200
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Farnesyltransferase inhibitor SCH‐66336 downregulates secretion of matrix proteinases and inhibits carcinoma cell migrationInternational Journal of Cancer, 2005
- The p38 SAPK pathway is required for Ha-ras induced in vitro invasion of NIH3T3 cellsExperimental Cell Research, 2005
- Assembly and function of RNA silencing complexesNature Reviews Molecular Cell Biology, 2005
- Expression and Functional Role of CCR9 in Prostate Cancer Cell Migration and InvasionClinical Cancer Research, 2004
- Is gene therapy the answer for prostate cancer?Prostate Cancer and Prostatic Diseases, 2004
- Intravenous RNA Interference Gene Therapy Targeting the Human Epidermal Growth Factor Receptor Prolongs Survival in Intracranial Brain CancerClinical Cancer Research, 2004
- Expression of antisense uPAR and antisense uPA from a bicistronic adenoviral construct inhibits glioma cell invasion, tumor growth, and angiogenesisOncogene, 2003
- Downregulation of uPA inhibits migration and PI3k/Akt signaling in glioblastoma cellsOncogene, 2003
- Cancer Statistics, 2003CA: A Cancer Journal for Clinicians, 2003
- Binding of Urokinase-type Plasminogen Activator to Its Receptor in MCF-7 Cells Activates Extracellular Signal-regulated Kinase 1 and 2 Which Is Required for Increased Cellular MotilityPublished by Elsevier ,1998